Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 14, 2025
Abstract
High‐intensity
focused
ultrasound
(HIFU)
is
emerging
as
a
promising
non‐invasive
treatment
for
solid
tumors.
Nevertheless,
HIFU
may
also
induce
the
upregulation
of
Heat
Shock
Protein
90
(HSP‐90),
potentially
resulting
in
resistance
to
HIFU.
Besides,
although
it
effective
against
situ
tumors,
challenges
remain
with
tumor
metastasis
and
recurrence.
Herein,
innovative
design
gambogic
acid
(GA)
based
coordination
polymer—GAZn‐PEG
nanoparticles
(GAZn‐PEG
NPs)
are
synthesized
through
GA
zinc
ions
(Zn
2+
),
subsequently
functionalized
lipid
bilayer
incorporating
polyethylene
glycol
(PEG),
sensitizing
cervical
ovarian
cancers.
Briefly,
under
exposure,
markedly
suppresses
expression
HSP‐90,
thereby
increasing
tumor's
sensitivity
therapy.
Furthermore,
Zn
not
only
overcome
issue
GA's
poor
water
solubility
but
synergistically
stimulate
immune
responses
conjunction
GA.
More
intriguingly,
has
been
discovered
that
GAZn‐PEG
can
effectively
activate
cyclic
GMP‐AMP
synthase‐stimulator
interferon
genes
(cGAS‐STING)
pathway,
enhancing
provoked
by
Specifically,
NPs
show
remarkable
increase
dendritic
cell
activation
stimulation
cGAS‐STING
crucial
long‐term
protection
recurrence
metastasis.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 857 - 857
Published: April 2, 2025
Background/Objectives:
Natural
killer
(NK)
cells
play
a
crucial
role
in
tumor
surveillance
by
exerting
cytotoxic
activity
and
modulating
immune
responses.
However,
tumors
employ
diverse
evasion
strategies
that
limit
NK
cell
effectiveness.
This
review
aims
to
explore
the
molecular
mechanisms
of
activation
inhibition
cancer,
influence
microenvironment,
latest
advancements
cell-based
immunotherapies,
including
adoptive
transfer
Chimeric
Antigen
Receptor-Natural
Killer
(CAR-NK)
therapies.
Methods:
A
comprehensive
literature
was
conducted,
prioritizing
peer-reviewed
studies
from
last
decade
on
biology,
evasion,
immunotherapeutic
applications.
The
analysis
includes
data
preclinical
models
clinical
trials
evaluating
expansion
strategies,
cytokine-based
stimulation,
CAR-NK
therapy
developments.
Results:
eliminate
through
granule
release,
death
receptor
pathways,
cytokine
secretion.
evade
NK-mediated
immunity
downregulating
activating
ligands,
secreting
immunosuppressive
molecules,
altering
microenvironment.
Novel
therapies,
such
as
combination
approaches
with
checkpoint
inhibitors,
enhance
persistence
therapeutic
efficacy
against
both
hematologic
solid
malignancies.
Clinical
suggest
improved
safety
profiles
compared
CAR-T
reduced
release
syndrome
graft-versus-host
disease.
Conclusions:
While
immunotherapies
hold
great
promise,
challenges
remain,
limited
tumor-induced
immunosuppression.
Addressing
these
hurdles
will
be
critical
for
optimizing
therapies
advancing
next-generation,
off-the-shelf
immunotherapeutics
broader
Molecular Immunology,
Journal Year:
2025,
Volume and Issue:
182, P. 54 - 61
Published: April 4, 2025
Natural
Killer
(NK)
cells
are
a
vital
element
of
the
innate
immune
system,
and
NK
cell-based
therapies
have
demonstrated
efficacy
against
various
malignancies.
However,
targeting
solid
tumors
has
been
challenging
due
to
low
infiltration
into
effective
evasion
strategies
employed
by
tumors.
Recent
studies
shown
that
cell
derived
nanovesicles
(NK-NV)
can
not
only
replicate
functions
but
also
offer
more
advantages
in
clinical
applications.
They
capable
transporting
cellular
components
such
as
proteins,
nucleic
acids,
lipids
across
distances,
thereby
facilitating
intercellular
communication
among
within
tumor
microenvironment
(TME).
With
progress
nanomedical
technology,
these
vesicles
be
engineered
carry
range
functional
elements
therapeutic
agents
enhance
their
antitumoral
capabilities.
In
this
review,
we
summarize
current
available
literature
on
NK-NVs,
discuss
potential
biological
role
non-coding
RNAs
(ncRNAs),
explore
application
treatment
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 9, 2025
Gemcitabine
(GEM),
a
nucleoside
analog
chemotherapy
agent,
has
been
widely
used
in
the
treatment
of
various
cancers.
In
recent
years,
there
growing
interest
understanding
immunomodulatory
or
immunosuppressive
effects
GEM.
The
roles
GEM
could
influence
anti-tumor
immune
responses
via
several
mechanisms,
such
as
modulation
antigen
presentation,
cytokine
production,
and
cell
population.
Furthermore,
is
evidence
that
enhances
therapeutic
efficacy
immunotherapies,
including
oncolytic
viruses,
checkpoint
inhibitors,
CAR
T-cells,
vaccines.
On
other
hand,
accumulating
also
proposed
may
act
an
agent
within
tumor
microenvironment,
resulting
evasion
cells
growth.
These
paradoxical
modifying
highlight
complexity
interaction
with
microenvironment.
This
review
aims
to
provide
overview
microenvironment
how
affects
cancer
immunotherapy.
Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 14, 2025
Abstract
High‐intensity
focused
ultrasound
(HIFU)
is
emerging
as
a
promising
non‐invasive
treatment
for
solid
tumors.
Nevertheless,
HIFU
may
also
induce
the
upregulation
of
Heat
Shock
Protein
90
(HSP‐90),
potentially
resulting
in
resistance
to
HIFU.
Besides,
although
it
effective
against
situ
tumors,
challenges
remain
with
tumor
metastasis
and
recurrence.
Herein,
innovative
design
gambogic
acid
(GA)
based
coordination
polymer—GAZn‐PEG
nanoparticles
(GAZn‐PEG
NPs)
are
synthesized
through
GA
zinc
ions
(Zn
2+
),
subsequently
functionalized
lipid
bilayer
incorporating
polyethylene
glycol
(PEG),
sensitizing
cervical
ovarian
cancers.
Briefly,
under
exposure,
markedly
suppresses
expression
HSP‐90,
thereby
increasing
tumor's
sensitivity
therapy.
Furthermore,
Zn
not
only
overcome
issue
GA's
poor
water
solubility
but
synergistically
stimulate
immune
responses
conjunction
GA.
More
intriguingly,
has
been
discovered
that
GAZn‐PEG
can
effectively
activate
cyclic
GMP‐AMP
synthase‐stimulator
interferon
genes
(cGAS‐STING)
pathway,
enhancing
provoked
by
Specifically,
NPs
show
remarkable
increase
dendritic
cell
activation
stimulation
cGAS‐STING
crucial
long‐term
protection
recurrence
metastasis.